Pfizer Inc is considering a collaboration with German drugmaker BioNTech SE to develop vaccines for the coronavirus using BioNTech's mRNA-based drug development platform, Pfizer's R&D head told Reuters on Thursday.
from Reuters: Health News https://ift.tt/32UyU3j
via
IFTTT
0 comments:
Post a Comment